Former Pfizer CEO, finance chief step back from Starboard’s activist campaign

Former Pfizer CEO, finance chief step back from Starboard’s activist campaign


Ian Read, chairman and chief executive officer of Pfizer, speaks as President Donald Trump, left, listens during an announcement on a new pharmaceutical glass packaging initiative in the Roosevelt Room of the White House in Washington, D.C., July 20, 2017. 

Andrew Harrer | Bloomberg | Getty Images

Former Pfizer CEO Ian Read and ex-CFO Frank D’Amelio said Wednesday evening that they would step away from Starboard Value’s campaign at the struggling pharmaceutical giant, just days after news of the activist’s stake broke.

Read and D’Amelio said they were “fully supportive” of Pfizer CEO Albert Bourla in a joint statement made via an investment bank and confirmed to be authentic. The duo had been in contact with a number of directors shortly before news of Starboard’s stake broke Sunday evening, according to people familiar with the matter.

“We are confident that over time they will deliver shareholder value,” the two former executives said of Pfizer’s current board and management. The company’s shares are essentially flat for the year and are off by roughly 50% from their 2021 highs.

The about face comes as Pfizer’s board grapples with the activist’s efforts, and just days before Starboard’s Jeff Smith was slated to meet with CEO Bourla, said people familiar with the matter. For executives to join, and then walk away from an activist’s campaign is highly unusual.

It was also not immediately clear what impact, if any, the breakaway would have on Starboard’s campaign. A representative for the activist fund did not immediately return a request for comment. Starboard, one of the largest and most tenacious activist funds, has amassed a roughly $1 billion position in the pharmaceutical firm, CNBC previously reported.

Jeff Smith, the managing member at Starboard, has previously mounted campaigns at Autodesk and Salesforce in recent months. While it typically focuses on the technology sector, it also built stakes in Starbucks and Wall Street Journal parent News Corp this year.

Representatives for Pfizer did not immediately return requests for comment.

This is a developing story. Please check back for updates.



Source

Bill Gates meets Willy Wonka: How Epic’s 82-year-old billionaire CEO, Judy Faulkner, built her software factory
Health

Bill Gates meets Willy Wonka: How Epic’s 82-year-old billionaire CEO, Judy Faulkner, built her software factory

Judy Faulkner, founder and chief executive officer of Epic Systems Corp., during the Forbes Healthcare Summit in New York, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Do not go public. Do not acquire or be acquired. Software must work. These are the first three of the 10 commandments splashed across bathrooms and […]

Read More
UnitedHealth shares jump the most in 5 years after Buffett’s new stake is revealed
Health

UnitedHealth shares jump the most in 5 years after Buffett’s new stake is revealed

UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle | Bloomberg | Getty Images Stock Chart IconStock chart icon UnitedHealth Friday Shares of UnitedHealth were down nearly 50% for 2025 through Thursday’s close before Buffett’s filing. The largest private health insurer has become the face […]

Read More
Nike co-founder Phil Knight to donate  billion to OHSU’s Knight Cancer Institute
Health

Nike co-founder Phil Knight to donate $2 billion to OHSU’s Knight Cancer Institute

Phil Knight Matthew Staver | Bloomberg | Getty Images Nike co-founder Phil Knight is donating $2 billion to the Oregon Health and Science University’s Knight Cancer Institute, the single largest donation ever to a U.S. university, college or health institution, according to the Knight Foundation. The foundation said on Thursday the gift that will be […]

Read More